🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 53566P109 (prev. 09066L105 )
- Market Cap
- Small Cap
- Previous Symbol
- BTX (changed 8/12/2019)
- Previous Name
- BioTime, Inc.
Business: BioTime, Inc. is a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer.
Notes: Jan. 4, 2016 -- OncoCyte said today that it has spun off as a publicly traded company from BioTime and has begun trading on the NYSE MKT under the symbol OCX. On Dec. 31, 2015, BioTime distributed approximately 4.75 million shares of OncoCyte common stock to its shareholders in the ratio of one share of OncoCyte stock for every 20 BioTime common shares owned. There are now 25.4 million shares outstanding of OncoCyte, of which BioTime owns 58.55 percent.
Company Contact
- CEO
- Brian Culley
- CFO
- Jill Howe
- CEO
- Adi Mohanty
- Headquarters
- 2173 Salk Avenue, Suite 200, Carlsbad, CA 92008
- Phone
- 442-287-8990
- Investor Relations
- Ioana C. Hone · 510-871-4188 · IR@lineagecell.com